financetom
Business
financetom
/
Business
/
Update: Nvidia Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Q4 Outlook Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Nvidia Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Q4 Outlook Set
Nov 20, 2024 7:41 PM

05:02 PM EST, 11/20/2024 (MT Newswires) -- (Updates the stock change in the last paragraph.)

Nvidia ( NVDA ) reported fiscal Q3 non-GAAP earnings late Wednesday of $0.81 per diluted share, up from $0.40 a year earlier.

Analysts polled by FactSet expected $0.75 excluding some items.

Revenue in the three months ended Oct. 27 rose to $35.08 billion from $18.12 billion a year earlier.

Analysts surveyed by FactSet expected $33.17 billion.

The company expects fiscal Q4 revenue of $37.5 billion, plus or minus 2%. Analysts expect $37.09 billion.

Nvidia ( NVDA ) shares fell 0.7% in after-hours activity, paring earlier losses.

Price: 144.81, Change: -1.08, Percent Change: -0.74

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bezos' Blue Origin delays New Glenn debut launch
Bezos' Blue Origin delays New Glenn debut launch
Jan 13, 2025
WASHINGTON, Jan 13 (Reuters) - Jeff Bezos' Blue Origin called off the launch of its New Glenn rocket after a few anomalies during the mission countdown on Monday, postponing by at least a day an inaugural attempt to reach orbit and compete with SpaceX in the satellite launch market. ...
Arcellx Insider Sold Shares Worth $2,263,942, According to a Recent SEC Filing
Arcellx Insider Sold Shares Worth $2,263,942, According to a Recent SEC Filing
Jan 13, 2025
03:22 AM EST, 01/13/2025 (MT Newswires) -- Rami Elghandour, Director, President, Chief Executive Officer and Chairman of the Board, on January 07, 2025, sold 30,311 shares in Arcellx ( ACLX ) for $2,263,942. Following the Form 4 filing with the SEC, Elghandour has control over a total of 117,275 shares of the company, with 117,275 shares held directly. SEC Filing:...
Arcellx Insider Sold Shares Worth $1,355,024, According to a Recent SEC Filing
Arcellx Insider Sold Shares Worth $1,355,024, According to a Recent SEC Filing
Jan 13, 2025
03:22 AM EST, 01/13/2025 (MT Newswires) -- Michelle Gilson, Chief Financial Officer, on January 07, 2025, sold 18,009 shares in Arcellx ( ACLX ) for $1,355,024. Following the Form 4 filing with the SEC, Gilson has control over a total of 9,582 shares of the company, with 9,582 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1786205/000141588925001345/xslF345X05/form4-01112025_020131.xml ...
GSK to Acquire Oncology Firm IDRx for Up to $1.15 Billion
GSK to Acquire Oncology Firm IDRx for Up to $1.15 Billion
Jan 13, 2025
03:21 AM EST, 01/13/2025 (MT Newswires) -- GSK (GSK) has agreed to acquire oncology company IDRx for up to $1.15 billion, the companies said Monday. The consideration includes $1 billion in an upfront payment, and up to $150 million in potential regulatory-based milestone payments. GSK will also be responsible for milestone and royalty payments owed to Merck KGaA related to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved